retatrutide mechanism of action retatrutide clinical trials 2024 2025 (LY-3437943) Market Analysis, 2033: Triple-Agonist Therapy Landscape In Obesity And Metabolic Disorders Retatrutide Research Guide: What the
Description
Cardiovascular benefits are particularly relevant for women over 40, who face increasing heart disease risk after menopause
Average weight loss of 810% of body weight
Using both medications, for suppression and weight loss concurrently is not recommended as it can worsen potential side effects without offering significant benefits in terms of weight loss outcomes
Examples include Greek yogurt with nuts, a protein smoothie, or eggs with turkey sausage
